← Назад

Andersen-Tawil syndrome

ORPHA:37553DiseaseAutosomal dominantChildhood

Ассоциированные гены (2)

KCNJ2
potassium inwardly rectifying channel subfamily J member 2
Disease-causing germline mutation(s) in
OMIM: 600681
KCNJ5
potassium inwardly rectifying channel subfamily J member 5
Disease-causing germline mutation(s) in
OMIM: 600734

Фенотипы (51)

Облигатный (100%)2
HP:0003768Periodic paralysis
HP:0001324Muscle weakness
Очень частый (80–99%)1
HP:0003752Episodic flaccid weakness
Частый (30–79%)7
HP:0000164Abnormality of the dentition
HP:0000347Micrognathia
HP:0001657Prolonged QT interval
HP:0001999Abnormal facial shape
HP:0004308Ventricular arrhythmia
HP:0004322Short stature
HP:0008153Periodic hypokalemic paresis
Периодический (5–29%)38
HP:0001382Joint hypermobility
HP:0000218High palate
HP:0000219Thin upper lip vermilion
HP:0000316Hypertelorism
HP:0000324Facial asymmetry
HP:0000325Triangular face
HP:0000327Hypoplasia of the maxilla
HP:0000337Broad forehead
HP:0000369Low-set ears
HP:0000414Bulbous nose
HP:0000431Wide nasal bridge
HP:0000677Oligodontia
HP:0000678Dental crowding
HP:0000859Hyperaldosteronism
HP:0001250Seizure
HP:0001328Specific learning disability
HP:0001510Growth delay
HP:0001644Dilated cardiomyopathy
HP:0001664Torsade de pointes
HP:0001773Short foot
HP:0001864Clinodactyly of the 5th toe
HP:0001962Palpitations
HP:0002650Scoliosis
HP:00046912-3 toe syndactyly
HP:0005135Abnormal T-wave
HP:0005147Bidirectional ventricular ectopy
HP:0005184Prolonged QTc interval
HP:0006335Persistence of primary teeth
HP:0006682Ventricular extrasystoles
HP:0006696Polymorphic and polytopic ventricular extrasystoles
HP:0007215Periodic hyperkalemic paralysis
HP:0011073Abnormality of dental color
HP:0012745Short palpebral fissure
HP:0012758Neurodevelopmental delay
HP:0025072Prominent U wave
HP:0030799Scaphocephaly
HP:0031677Polymorphic ventricular tachycardia
HP:0200055Small hand
Очень редкий (1–4%)3
HP:0000089Renal hypoplasia
HP:0000124Renal tubular dysfunction
HP:0001279Syncope

Эпидемиология (4)

Annual incidence
1-9 / 1 000 000
Europe
Point prevalence
Unknown
Worldwide
Point prevalence
<1 / 1 000 000
United Kingdom
Point prevalence
1-9 / 1 000 000
Netherlands

Лекарства и терапия

Источник: Open Targets Platform (в реальном времени)

Клинические исследования

Источник: ClinicalTrials.gov (в реальном времени)

Внешние ресурсы